Keyphrases
Diabetes
100%
Obesity
100%
Vascular Dysfunction
100%
β-site APP-cleaving Enzyme 1 (BACE1)
75%
Amyloid Precursor Protein
75%
Cyclic GMP
50%
Protein Kinase G
50%
Endothelial Nitric Oxide Synthase (eNOS)
50%
Nitric Oxide Production
50%
Endothelial Dysfunction
50%
Vascular Disease
50%
Raised Blood Pressure
50%
Endothelin-1 (ET-1)
50%
Diet-induced Obesity
50%
Alzheimer's Disease
25%
Causal Relationship
25%
Hyperglycemia
25%
Therapeutic Value
25%
Disease-associated
25%
Control Diet
25%
Vascular Complications
25%
Disease Development
25%
Diabetes Disease
25%
Nitric Oxide Bioavailability
25%
Obesity-related Diseases
25%
Vascular Relaxation
25%
BACE1 Inhibitor
25%
Cyclic Protein
25%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
100%
Amyloid Precursor Protein
100%
Amyloid Protein
100%
Endothelial Dysfunction
66%
Vascular Disease
66%
Endothelin 1
66%
Diet Induced Obesity
66%
Cyclic GMP Dependent Protein Kinase
66%
Bioavailability
33%
Hyperglycemia
33%
Hyperlipidemia
33%
Nitric Oxide Synthase
33%
Disease Course
33%
Alzheimer's Disease
33%
Endothelial Nitric Oxide Synthase
33%
Cyclic GMP
33%
Medicine and Dentistry
Diabetes
100%
Amyloid Protein
100%
Nitric Oxide
60%
Amyloid Precursor Protein
60%
Blood Pressure
40%
Vascular Disease
40%
Endothelial Dysfunction
40%
Endothelin 1
40%
Diet Induced Obesity
40%
Cyclic GMP Dependent Protein Kinase
40%
Bioavailability
20%
Hyperglycemia
20%
Hyperlipidemia
20%
Nitric Oxide Synthase
20%
Infusion
20%
Alzheimer's Disease
20%
Disease Course
20%
Endothelial Nitric Oxide Synthase
20%
Cyclic GMP
20%
Neuroscience
Nitric Oxide
100%
Amyloid Precursor Protein
100%
Amyloid Protein
100%
CGMP-dependent Protein Kinase
66%
Vascular Disease
66%
Endothelin 1
66%
Blood Plasma
66%
Alzheimer's Disease
33%
Endothelial Nitric Oxide Synthase
33%
Hyperglycemia
33%
Nitric Oxide Synthase
33%
Cyclic Guanosine Monophosphate
33%